← American Well Corp
| Annual Trend | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|
| Net loss | ($52.3m) | ($88.4m) | ($228.6m) | ($176.8m) | ($272.1m) | ($679.2m) | ($212.6m) | ($95.0m) | — | |
| Depreciation and amortization expense | $5.3m | $7.8m | $10.2m | $16.1m | $26.2m | $31.5m | $33.0m | $34.0m | $32.5m | |
| Amortization of deferred contract acquisition costs | $746k | $1.1m | $1.4m | $2.0m | $1.7m | $2.3m | $2.5m | $2.6m | — | |
| Amortization of deferred contract fulfillment costs | $574k | $707k | $852k | $737k | $620k | $432k | $459k | $1.0m | — | |
| Deferred income taxes | — | ($1.4m) | — | ($6.2m) | ($2.5m) | ($242k) | ($243k) | ($1.1m) | ($1.1m) | |
| Stock-based compensation expense | $7.7m | $12.1m | $118.4m | $43.8m | $67.7m | $72.2m | $47.5m | $22.0m | $13.0m | |
| Goodwill impairment | — | — | — | — | — | $436.5m | $0 | $0 | $3.9m | |
| Investment impairment | — | — | — | — | — | $0 | $0 | $1.0m | — | |
| Loss on equity method investment | — | — | $2.2m | $3.1m | $2.3m | $2.6m | $3.1m | $1.7m | — | |
| Accounts receivable | ($19.5m) | $803k | ($14.2m) | ($512k) | ($8.1m) | $3.2m | ($25.0m) | $12.2m | ($4.2m) | |
| Inventory provisions | $673k | — | — | — | — | $0 | $1.9m | $500k | — | |
| Inventories | $1.6m | ($592k) | ($6.0m) | $1.6m | ($1.2m) | $2.1m | $1.9m | $1.2m | $1.0m | |
| Accounts payable | ($787k) | $1.2m | ($707k) | $5.5m | ($4.8m) | ($2.4m) | $159k | ($3.4m) | ($2.0m) | |
| Accrued expenses and other current liabilities | $2.7m | $5.9m | $12.9m | ($380k) | $9.0m | ($15.1m) | $10.1m | ($3.6m) | — | |
| Deferred revenue | ($17.0m) | ($16.1m) | ($2.2m) | ($9.4m) | ($19.7m) | ($3.5m) | $3.8m | ($33.0m) | — | |
| Prepaid expenses and other current assets | ($2.9m) | ($2.7m) | ($6.0m) | ($5.8m) | ($161k) | $4.7m | $2.6m | $871k | — | |
| Other assets | ($213k) | ($977k) | $122k | $117k | ($235k) | ($76k) | ($217k) | $779k | — | |
| Net cash used in operating activities | ($74.0m) |
($81.9m)
-10.66%
|
($112.5m)
-37.33%
|
($141.5m)
-25.85%
|
($192.3m)
-35.88%
|
($148.3m)
+22.87%
|
($127.3m)
+14.16%
|
($66.0m)
+48.21%
|
($26.4m)
+59.99%
|
|
| Purchases of property and equipment | ($1.9m) | ($1.3m) | ($3.3m) | ($559k) | ($292k) | ($192k) | ($119k) | ($21k) | ($5.7m) | |
| Accretion of discounts on debt securities | — | — | — | — | — | ($10.0m) | $0 | $0 | — | |
| Interest on debt securities | — | — | — | — | — | $10.0m | $0 | $0 | — | |
| Purchases of investments | ($355.2m) | ($78.9m) | ($159.6m) | — | ($499.2m) | ($390.0m) | $0 | ($1.0m) | — | |
| Proceeds from sales and maturities of investments | $175.6m | $246.0m | $99.1m | $100.0m | $500.0m | $390.0m | $0 | $0 | — | |
| Net gain on divestiture | — | — | — | — | — | $0 | $0 | ($8.6m) | — | |
| Net proceeds from divestiture | — | — | — | — | — | $0 | $0 | $18.3m | — | |
| Acquisitions of business, net of cash acquired | ($64.4m) | ($45.8m) | — | ($156.5m) | — | — | — | — | — | |
| Issuance of common stock in acquisitions | — | — | — | $144.1m | — | — | — | — | $0 | |
| Net cash provided by (used in) investing activities | ($245.9m) | $120.0m | ($66.8m) | ($59.6m) | ($11.6m) | ($19.2m) | ($18.7m) | $17.1m | ($903k) | |
| Proceeds from exercise of common stock options | $635k | $1.0m | $5.9m | $20.8m | $5.7m | $569k | $0 | $0 | — | |
| Issuance of common stock in settlement of earnout | — | — | — | — | $17.2m | — | — | — | $0 | |
| Receivable related to exercise of common stock options | — | — | — | $74k | — | — | — | — | — | |
| Net cash provided by financing activities | $278.2m |
$46.6m
-83.23%
|
$983.1m
+2007.93%
|
$5.8m
-99.41%
|
($3.6m)
-162.77%
|
$2.1m
+159.44%
|
$1.4m
-35.68%
|
$840k
-39.17%
|
$601k
-28.45%
|
|
| Cash, cash equivalents, and restricted cash at beginning of period | $54.1m | $138.8m | $942.7m | $747.2m | $539.3m | $372.8m | $229.1m | $183.1m | — | |
| Effect of exchange rates changes on cash, cash equivalents, and restricted cash | — | — | — | ($84k) | ($305k) | ($1.1m) | $887k | $2.0m | — | |
| Net decrease in cash, cash equivalents, and restricted cash | ($41.8m) | $84.7m | $803.9m | ($195.5m) | ($207.9m) | ($166.5m) | ($143.7m) | ($46.0m) | — | |
| Restricted cash | $6.1m | $1.1m | $1.1m | $795k | $795k | $795k | $795k | $795k | — | |
| Additional Supplementary Disclosures | ||||||||||
| Additional Supplementary Disclosures | ||||||||||
| Provisions for credit losses | $211k | $717k | $1.6m | $714k | $806k | $1.1m | $7.1m | $2.7m | — | |
| Noncash compensation costs incurred by selling shareholders | — | — | — | $2.8m | $11.1m | — | — | — | — | |
| Deferred contract acquisition costs | ($1.2m) | ($1.2m) | ($2.1m) | ($2.2m) | ($2.8m) | ($4.5m) | ($3.3m) | ($1.8m) | — | |
| Other long-term liabilities | $481k | ($699k) | ($245k) | ($16.7m) | ($25k) | — | — | — | — | |
| Capitalized software development costs | — | — | — | — | ($10.2m) | ($15.1m) | ($15.1m) | $0 | — | |
| Investment in less than majority owned joint venture | — | — | ($2.9m) | ($2.5m) | ($2.0m) | ($3.9m) | ($3.4m) | ($196k) | — | |
| Proceeds from employee stock purchase plan | — | — | — | $1.6m | $2.5m | $2.2m | $1.4m | $844k | — | |
| Payments for the purchase of treasury stock | — | ($158k) | ($37.6m) | ($15.0m) | ($360k) | ($586k) | ($3k) | ($4k) | — | |
| Proceeds from Section 16(b) disgorgement | — | — | — | — | $295k | — | — | — | — | |
| Payment of contingent consideration | — | — | — | — | ($11.8m) | — | — | — | — | |
| Payment of deferred offering costs | — | — | ($3.3m) | ($1.6m) | — | — | — | — | — | |
| Cash and cash equivalents | $48.0m | $137.7m | $941.6m | $746.4m | $538.5m | $372.0m | $228.3m | $182.3m | $219.9m | |
| Cash paid for income taxes | — | $193k | $713k | $1.6m | $1.7m | $5.0m | $4.1m | $2.0m | — |